A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Canada balsam | for microscopy. Group: Immersion oils. |  |
| Canada balsam | Canada balsam. Synonyms: Balsam Canada. CAS No. 8007-47-4. Pack Sizes: 25, 100 mL in glass bottle. Product ID: CDC10-0192. Molecular formula: n.a. Category: Flavoring Chemical Agents. Product Keywords: Cosmetic Ingredients; Flavoring Chemical Agents; Canada balsam; CDC10-0192; 8007-47-4; Balsam Canada; 232-362-2; MFCD00132800; 8007-47-4. Purity: 0.99. Color: yellow to very dark yellow. EC Number: 232-362-2. Physical State: Liquid. Solubility: Chloroform. Quality Level: 100. Storage: Store at 5°C to 30°C. Application: Canada balsam is used as a stable apolar hydrophobic mounting medium for light microscopy slide preparation, especially when long-term storage is desired. It is mostly applicable for cellular staining. Density: 0.99 g/mL. Product Description: Canada Balsam is a natural mounting medium obtained from balsam fir trees. It is produced from the resin of the balsam fir tree and its use can be combined with xylene-containing specimens. The optical properties of Canada Balsam are nearly identical to those of glass. Specimens must be dehydrated before using this medium. Permanent slides mounted with Canada Balsam have been stored for over a century. |  |
| Canada Balsam | Canada Balsam. Group: Biochemicals. Alternative Names: Canada Balsams; Canada Turpentine. Grades: Highly Purified. CAS No. 8007-47-4. Pack Sizes: 10g. US Biological Life Sciences. |  Worldwide |
| Canada Balsam | 100g Pack Size. Group: Analytical Reagents, Building Blocks, Organics. Formula: N/A. CAS No. 8007-47-4. Prepack ID 31059610-100g. See USA prepack pricing. |  |
| Canada balsam solution | for microscopy. Group: Immersion oils. | |
| Canadensolide | Canadensolide is a bislactone antibiotic isolated from Penicillium canadense, Aspergillus flavus and A. tamarii. It shows antifungal activity. Synonyms: (-)-Canadensolide; Furo(3,4-b)furan-2,4-dione, 6-butyltetrahydro-3-methylene-, (3aS,6R,6aR)-; (3aS,6R,6aR)-6-Butyl-3-methylenetetrahydrofuro[3,4-b]furan-2,4-dione. CAS No. 20421-31-2. Molecular formula: C11H14O4. Mole weight: 210.23. |  |
| Canadian balsam,neutral | Canadian balsam,neutral. Group: Polymers. Alternative Names: CANADIAN BALSAM, NEUTRAL; balsamforopticalglass; balsamoffir; Balsams,Canada; canadian; Canada turpentine; ABIES BALSAMEA (BALSAM CANADA) RESIN; AGAR, SHREDDED. CAS No. 8007-47-4. Molecular formula: 0. Mole weight: n.a. |  |
| Canadine | Canadine is a protoberberine alkaloid which potently block functional KATP channels natively expressed on midbrain dopamine neurons. Canadine is used for treatment of degenerative diseases or conditions associated with KATP channel signaling. Group: Biochemicals. Alternative Names: 5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine; 9-Deoxy-16,17-dihydroberberine; 9, 10-Dimethoxy-2, 3- (methylenedioxy) berbine; (±)-Canadine; (±)-Tetrahydroberberine; Tetrahydroberberine,; NSC 36351; NSC 94918; Tetrahydroberberine; Tetrahydroumbellatine; Xanthopuccine; dl-Canadine; dl-Tetrahydroberberine. Grades: Highly Purified. CAS No. 522-97-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Canadine | Canadine. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DL-TETRAHYDROBERBERINE;DL-CANADINE;9,10-DIMETHOXY-5,8,13,13A-TETRAHYDRO-6H-[1,3]DIOXOLO[4,5-G]ISOQUINO[3,2-A]ISOQUINOLINE;AKOS 213-56;5,8,13,13A-TETRAHYDRO-9,10-DIMETHOXY-6H-BENZO[G]-1,3-BENZODIOXOLO[5,6-ALPHA]QUINOLIZINE;THB;TETRAHYDROBERBERINE;(+-)-can. Product Category: Heterocyclic Organic Compound. CAS No. 29074-38-2. Molecular formula: C20H21NO4. Mole weight: 339.39. Product ID: ACM29074382. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Canagliflozin | Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. Group: Biochemicals. Alternative Names: (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol. Grades: Highly Purified. CAS No. 842133-18-0. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Canagliflozin | Canagliflozin is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. Synonyms: D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-; JNJ-24831754; TA-7284; JNJ 24831754; TA 7284; JNJ24831754; TA7284; (1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thien-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; 1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene; Invokana; JNJ 24831754ZAE; JNJ 28431754AAA. Grade: >98%. CAS No. 842133-18-0. Molecular formula: C24H25FO5S. Mole weight: 444.52. | |
| Canagliflozin | Canagliflozin (JNJ 28431754) is a selective SGLT2 inhibitor with IC 50 s of 2 nM, 3.7 nM, and 4.4 nM for mSGLT2, rSGLT2, and hSGLT2 in CHOK cells, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: JNJ 28431754. CAS No. 842133-18-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10451. |  |
| Canagliflozin | Canagliflozin. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene. Product Category: Thiophenes. Appearance: White to Pale Yellow Solid. CAS No. 842133-18-0. Molecular formula: C24H25FO5S. Mole weight: 444.52. Purity: 95%+. Product ID: ACM842133180. Alfa Chemistry ISO 9001:2015 Certified. | |
| Canagliflozin 2-Glucuronide | Canagliflozin 2-glucuronide is a derivative of Canagliflozin. Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that is used to treat patients with type 2 diabetes. Canagliflozin lowers blood glucose by increasing the amount of glucose that exits the body through urinary excretion. Synonyms: Canagliflozin metabolite M5; (2S,3S,4S,5R,6R)-6-(((2S,3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; 1-(2-O-β-D-Glucuronide-β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene. Grade: 96%. CAS No. 2648415-15-8. Molecular formula: C30H33FO11S. Mole weight: 620.64. | |
| Canagliflozin 3-Glucuronide | Canagliflozin 3-glucuronide is a derivative of Canagliflozin. Canagliflozin is a sodium-glucose cotransporter 2 inhibitor that is used to treat patients with type 2 diabetes. Canagliflozin lowers blood glucose by increasing the amount of glucose that exits the body through urinary excretion. Synonyms: Canagliflozin metabolite M7; (2S,3S,4S,5R,6R)-6-(((2S,3S,4R,5R,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid; 1-(3-O-β-D-Glucuronide-β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene. Grade: 96%. CAS No. 2648415-13-6. Molecular formula: C30H33FO11S. Mole weight: 620.64. | |
| Canagliflozin 3-O-β-D-glucuronide | Canagliflozin 3-O-β-D-glucuronide is an impurity of Canagliflozin, a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. Synonyms: (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-3-O-β-D-glucopyranuronosyl-D-glucitol. Molecular formula: C30H33FO11S. Mole weight: 620.64. | |
| Canagliflozin alpha-Isomer Impurity | epi-Canagliflozin is an epimeric impurity of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor and is used in the treatment of type 2 diabetes and obesity. Synonyms: (1R)-1,5-Anhydro-1-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-D-glucitol; epi-Canagliflozin; D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1R)-; (1R)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol; (2R,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; Canagliflozin alpha-Isomer; Canagliflozin α-isomer. Grade: ≥95%. CAS No. 1589590-87-3. Molecular formula: C24H25FO5S. Mole weight: 444.53. | |
| Canagliflozin-[d4] | Canagliflozin D4 is a labelled Canagliflozin. Canagliflozin is a medication used for the treatment of type 2 diabetes. Synonyms: (2S,3R,4R,5S,6R)-2-[3-({5-[4-fluoro(2,3,5,6-D4)phenyl]thiophen-2-yl}methyl)-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol. Grade: 98% HPLC. CAS No. 1997338-61-0. Molecular formula: C24H21D4FO5S. Mole weight: 448.54. | |
| Canagliflozin-[d6] | Canagliflozin-[d6] is the labelled analogue of Canagliflozin, which is an anti-diabetic medication used to improve blood sugar control in people with type 2 diabetes. Synonyms: Canagliflozin-D6; (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol-D6; Canagliflozin-(Methylphenyl)-d6; (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-(methyl-d3)phenyl-2,5,6-d3)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 1997338-60-9. Molecular formula: C24H19D6FO5S. Mole weight: 450.55. | |
| Canagliflozin Defluoro Impurity | Defluoro-Canagliflozin is an impurity of Canagliflozin, a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity. Synonyms: Canagliflozin Impurity A; Canagliflozin Desfluoro Impurity; D-Glucitol, 1,?5-anhydro-1-C-[4-methyl-3-[(5-phenyl-2-thienyl)?methyl]?phenyl]?-, (1S)?-; (1S)-1,?5-Anhydro-1-C-[4-methyl-3-[(5-phenyl-2-thienyl)?methyl]?phenyl]?-D-glucitol; Desfluoro Canagliflozin; (2R,3S,4R,5R,6S)-2-(Hydroxymethyl)-6-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol. Grade: ≥95%. CAS No. 842133-16-8. Molecular formula: C24H26O5S. Mole weight: 426.54. | |
| Canagliflozin Furanose Form (Mixture of Anomers) | Canagliflozin Furanose Form (Mixture of Anomers) is an impurity of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor and is used in the treatment of type 2 diabetes and obesity. Synonyms: D-Galactitol, 1,4-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-; Canagliflozin-10; Canagliflozin Impurity 17; (2R,3R,4R,5R)-2-((R)-1,2-dihydroxyethyl)-5-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydrofuran-3,4-diol. CAS No. 2161394-94-9. Molecular formula: C24H25FO5S. Mole weight: 444.52. | |
| Canagliflozin hemihydrate | Canagliflozin hemihydrate is a highly potent and selective inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. It is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes. Uses: The potential treatment of type 2 diabetes. Synonyms: (3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol hemihydrate; JNJ 28431754 hemihydrate; TA 7284 hemihydrate; JNJ-24831754-ZAE hemihydrate; JNJ-28431754-AAA hemihydrate; (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol hydrate (2:1); Cagliflozin hydrate; Invokana hemihydrate; 1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate. Grade: >98%. CAS No. 928672-86-0. Molecular formula: C24H25FO5S.1/2H2O. Mole weight: 453.53. | |
| Canagliflozin hemihydrate | Canagliflozin hemihydrate (JNJ28431754 hemihydrate) is a selective SGLT2 inhibitor with IC 50 s of 2 nM, 3.7 nM, and 4.4 nM for mSGLT2, rSGLT2, and hSGLT2 in CHOK cells, respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: JNJ 28431754 hemihydrate. CAS No. 928672-86-0. Pack Sizes: 10 mM * 1 mL; 100 mg; 500 mg; 1 g. Product ID: HY-I0383. | |
| Canagliflozin Impurity 14 | Canagliflozin Impurity 14 is an impurity of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor and is used in the treatment of type 2 diabetes and obesity. Synonyms: D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(3-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-; (2S,3R,4R,5S,6R)-2-(3-((5-(3-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 842133-17-9. Molecular formula: C24H25FO5S. Mole weight: 444.52. | |
| Canagliflozin Impurity 17 | Canagliflozin Impurity 17 is an impurity of Canagliflozin, which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes and obesity. Synonyms: Methanone, [5-(4-fluorophenyl)-2-thienyl](5-β-D-glucopyranosyl-2-methylphenyl)-; Methanone, (5-(4-fluorophenyl)-2-thienyl)(5-beta-D-glucopyranosyl-2-methylphenyl)-; Canagliflozin impurity 12; (5-(4-Fluorophenyl)thiophen-2-yl)(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)methanone; [5-(4-Fluorophenyl)-2-thienyl](5-β-D-glucopyranosyl-2-methylphenyl)methanone; Canagliflozin Impurity 2; Canagliflozin Keto Impurity. Grade: ≥95%. CAS No. 1951467-28-9. Molecular formula: C24H23FO6S. Mole weight: 458.50. | |
| Canagliflozin Impurity 20 | Canagliflozin Impurity 20. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol. CAS No. 1672658-93-3. Molecular formula: C24H25FO6S. Mole weight: 460.52. Catalog: APB1672658933. | |
| Canagliflozin impurity 25 | Canagliflozin impurity 25. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1071929-08-2. Molecular formula: C18H12FIOS. Mole weight: 422.26. Catalog: APB1071929082. | |
| Canagliflozin Impurity 52 | Canagliflozin Impurity 52. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene. CAS No. 1030825-20-7. Molecular formula: C18H14BrFS. Mole weight: 361.27. Catalog: APB1030825207. | |
| Canagliflozin Impurity B | Canagliflozin Impurity B. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1132832-75-7. Molecular formula: C18H12BrFOS. Mole weight: 375.25. Catalog: APB1132832757. | |
| Canagliflozin Monoacetyl Impurity | Canagliflozin Monoacetyl Impurity is an impurity of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor and is used in the treatment of type 2 diabetes and obesity. Synonyms: ((2R,3S,4R,5R,6S)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate; Canagliflozin impurity 03. CAS No. 2146135-87-5. Molecular formula: C26H27FO6S. Mole weight: 486.55. | |
| Canagliflozin Related Impurity 10 | an impurity of Canagliflozin. Synonyms: β-D-Glucopyranose, 1-C-[3-[[5-(4-fluorophenyl)?-2-thienyl]?methyl]?-4-methylphenyl]?-. Grade: > 95%. CAS No. 1799552-91-2. Molecular formula: C24H25FO6S. Mole weight: 460.53. | |
| Canagliflozin Related Impurity 14 | 2-(4-Fluorophenyl)-thiophene can be used to prepare Canagliflozin as sodium-dependent glucose co-transporter 2 (SGLT2) inhibitor for treatment of type 2 diabetes mellitus. Synonyms: Thiophene, 2-(4-fluorophenyl)?-. Grade: > 95%. CAS No. 58861-48-6. Molecular formula: C10H7FS. Mole weight: 178.23. | |
| Canagliflozin Related Impurity 9 | an impurity of Canagliflozin. Synonyms: (3R,4S,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one. Grade: > 95%. CAS No. 32384-65-9. Molecular formula: C18H42O6Si4. Mole weight: 466.86. | |
| Canagliflozin Ring Opening Impurity | Canagliflozin Ring Opening Impurity is an impurity of Canagliflozin, which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes and obesity. Synonyms: (2S,3R,4R,5R)-1-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)hexane-1,2,3,4,5,6-hexaol; D-Glucitol, 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-; 1-C-[3-[[5-(4-Fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol. Molecular formula: C24H27FO6S. Mole weight: 462.53. | |
| Canagliflozin Tetraacetate | Canagliflozin Tetraacetate is an intermediate in the synthesis of Canagliflozin which is a sodium/glucose cotransporter 2 (SGLT2) inhibitor and is used in the treatment of type 2 diabetes and obesity. Synonyms: (1S)-1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-Tetraacetate; Canagliflozin impurity 05; Tetra Acetyl Canagliflozin. Grade: 98%. CAS No. 866607-35-4. Molecular formula: C32H33FO9S. Mole weight: 612.66. | |
| Canakinumab | Canakinumab is a recombinant human anti-IL-1β monoclonal antibody used for the treatment of immune disorders such as rheumatoid arthritis and cryopyrin-associated periodic syndrome (CAPS). Synonyms: Ilaris; ACZ 885; ACZ885. CAS No. 914613-48-2. | |
| Canakinumab | Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC 50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Ilaris; ACZ 885. CAS No. 914613-48-2. Pack Sizes: 1 mg; 5 mg. Product ID: HY-108810. | |
| Cananga Oil | Cananga oil is an essential oilsderived from the flowers of cananga tree, which is native to Asia. It has a sweet, floral and slightly woody aroma The height of the Cananga tree can make harvesting dangerous, as it can reach several dozen meters The Cananga blossoms are then hydro-distilled to obtain the essential oil. In perfumery, Cananga essential oilshas long been viewed as a less-expensive alternative to the very pricey ylang-ylang essence. Today, Cananga essential oilshas been deemed as having it's own olfactory qualities. It has strong floral character and jasmine and woody facets. In aromatherapy, this oil is used as an antidepressant and as a sedative. it is also considered to be an aphrosidiac and is believed to stimulate the circulatory system. Uses: Cosmetic and Care, Essential Oils, Flavoring. Group: Plant Extracts. INCI Names: Cananga Odorata Flower Oil. Grades: FOOD GRADE. CAS No. 93686-30-7; 68606-83-7. Pack Sizes: 25 kgs Jerrycan, 200 kg Drums. Product ID: CN-001. Olfactive Profile: Floral, sweet, slightly woody, ylang-ylang like, balsamic. EC No: 281-092-1. FEMA No: 2232. Origin: Indonesia. |  New Jersey |
| Canbisol | Canbisol. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Canbisol;Nabidrox (Canbisol, Dihydronabilone);3-(1,1-Dimethylheptyl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9-diol. Product Category: Heterocyclic Organic Compound. CAS No. 56689-43-1. Molecular formula: C24H38O3. Mole weight: 374.561. Product ID: ACM56689431. Alfa Chemistry ISO 9001:2015 Certified. | |
| Cancer Cell Differentiation Compound Library | A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2140. Categories: Cancer Cell Differentiation Compounds Libraries. |  |
| Cancer Hydrolase KIAA1363 Inhibitor, JW480 (2-Isopropylphenyl-2- (2-naphthyl) ethylcarbamate, AADACL1 Inhibitor, Arylacetamide Deacetylase-Like 1 Inhibitor, NCEH1 Inhibitor, Neutral Cholesterol Ester Hydrolase 1 Inhibitor) | A membrane-permeable, highly potent and selective inhibitor against the 2-acetyl MAGE (monoakylglycerol ether) hydrolase KIAA1363/AADACL1 of both human (IC50=12nM; PC3 lysate) and murine (IC50=20nM; brain membrane samples) origin, with no significant effect toward other PC3 or murine brain serine hydrolase activities, including HSL, FAAH, and AChE. Readily crosses blood-brain barrier in mice and effectively suppresses PC3-derived tumor growth in mice in vivo (by 56% on day 33; 80mg/kg/day; o.g.). Also inhibits blood carboxylesterase. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| cancer procoagulant | Apparently produced only by malignant and fetal cells. Group: Enzymes. Enzyme Commission Number: EC 3.4.22.26. CAS No. 109456-80-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4200; cancer procoagulant; EC 3.4.22.26; 109456-80-6. Cat No: EXWM-4200. |  |
| Cancer related antigens BST-2 (126-134) | Cancer related antigens BST-2 (126-134) is a peptide corresponding to residues 126-134 of BST-2. BST-2 is a unique innate immunity gene with both antiviral and pro-tumor functions and therefore can serve as a paradigm for understanding the roles of other innate immunity genes in cancers. Synonyms: Cancer related antigens Bone marrow stromal antigen 2 (126-134). | |
| Cancer/testis antigen 1 (119-138) | Cancer/testis antigen 1 (119-138) is a 20-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (119-138); Cancer/testis antigen 6.1 (119-138); L antigen family member 2 (119-138). | |
| Cancer/testis antigen 1 (119-143) | Cancer/testis antigen 1 (119-143) is a 25-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (119-143); Cancer/testis antigen 6.1 (119-143); L antigen family member 2 (119-143). | |
| Cancer/testis antigen 1 (121-130) | Cancer/testis antigen 1 (121-130) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (121-130); Cancer/testis antigen 6.1 (121-130); L antigen family member 2 (121-130). | |
| Cancer/testis antigen 1 (123-137) | Cancer/testis antigen 1 (123-137) is a 15-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (123-137); Cancer/testis antigen 6.1 (123-137); L antigen family member 2 (123-137). | |
| Cancer/testis antigen 1 (124-134) | Cancer/testis antigen 1 (124-134) is a 11-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (124-134); Cancer/testis antigen 6.1 (124-134); L antigen family member 2 (124-134). | |
| Cancer/testis antigen 1 (124-135) | Cancer/testis antigen 1 (124-135) is a 12-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (124-135); Cancer/testis antigen 6.1 (124-135); L antigen family member 2 (124-135). | |
| Cancer/testis antigen 1 (127-136) | Cancer/testis antigen 1 (127-136) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (127-136); Cancer/testis antigen 6.1 (127-136); L antigen family member 2 (127-136). | |
| Cancer/testis antigen 1 (139-156) | Cancer/testis antigen 1 (139-156) is a 18-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (139-156); Cancer/testis antigen 6.1 (139-156); L antigen family member 2 (139-156). | |
| Cancer/testis antigen 1 (53-62) | Cancer/testis antigen 1 (53-62) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (53-62); Cancer/testis antigen 6.1 (53-62); L antigen family member 2 (53-62). | |
| Cancer/testis antigen 1 (60-72) | Cancer/testis antigen 1 (60-72) is a 13-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (60-72); Cancer/testis antigen 6.1 (60-72); L antigen family member 2 (60-72). | |
| Cancer/testis antigen 1 (80-88) | Cancer/testis antigen 1 (80-88) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (80-88); Cancer/testis antigen 6.1 (80-88); L antigen family member 2 (80-88). | |
| Cancer/testis antigen 1 (86-97) | Cancer/testis antigen 1 (86-97) is a 12-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (86-97); Cancer/testis antigen 6.1 (86-97); L antigen family member 2 (86-97). | |
| Cancer/testis antigen 1 (87-100) | Cancer/testis antigen 1 (87-100) is a 14-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (87-100); Cancer/testis antigen 6.1(87-100); L antigen family member 2 (87-100). | |
| Cancer/testis antigen 1 (87-111) | Cancer/testis antigen 1 (87-111) is a 25-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (87-111); Cancer/testis antigen 6.1 (87-111); L antigen family member 2 (87-111). | |
| Cancer/testis antigen 1 (89-100) | Cancer/testis antigen 1 (89-100) is a 12-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (89-100); Cancer/testis antigen 6.1 (89-100); L antigen family member 2 (89-100). | |
| Cancer/testis antigen 1 (91-101) | Cancer/testis antigen 1 (91-101) is a 11-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (91-101); Cancer/testis antigen 6.1 (91-101); L antigen family member 2 (91-101). | |
| Cancer/testis antigen 1 (92-100) | Cancer/testis antigen 1 (92-100) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (92-100); Cancer/testis antigen 6.1 (92-100); L antigen family member 2 (92-100). | |
| Cancer/testis antigen 1 (94-102) | Cancer/testis antigen 1 (94-102) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (94-102); Cancer/testis antigen 6.1 (94-102); L antigen family member 2 (94-102). | |
| Cancer/testis antigen 1 (95-107) | Cancer/testis antigen 1 (95-107) is a 13-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (95-107); Cancer/testis antigen 6.1 (95-107); L antigen family member 2 (95-107). | |
| Cancer/testis antigen 1 (96-104) | Cancer/testis antigen 1 (96-104) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (96-104); Cancer/testis antigen 6.1 (96-104); L antigen family member 2 (96-104). | |
| Cancer/testis antigen 1 (ORF2 (14-33)) | Cancer/testis antigen 1 (ORF2 (14-33)) is a 20-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (ORF2 (14-33)); Cancer/testis antigen 6.1 (ORF2 (14-33)); L antigen family member 2 (ORF2 (14-33)). | |
| Cancer/testis antigen 1 (ORF2 (18-27)) | Cancer/testis antigen 1 (ORF2 (18-27)) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (ORF2 (18-27)); Cancer/testis antigen 6.1 (ORF2 (18-27)); L antigen family member 2 (ORF2 (18-27)). | |
| Cancer/testis antigen 2 (103-111) | Cancer/testis antigen 2 (103-111) is amino acids 103 to 111 fragment of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (103-111); Cancer/testis antigen 6.2 (103-111); L antigen family member 1 (103-111). | |
| Cancer/testis antigen 2 (108-120) | Cancer/testis antigen 2 (108-120) is amino acids 108 to 120 fragment of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (108-120); Cancer/testis antigen 6.2 (108-120); L antigen family member 1 (108-120). | |
| Cancer/testis antigen 2 (37-50) | Cancer/testis antigen 2 (37-50) is amino acids 37 to 50 fragment of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (37-50); Cancer/testis antigen 6.2 (37-50); L antigen family member 1 (37-50). | |
| Cancer/testis antigen 2 (ORF2 (1-11)) | Cancer/testis antigen 2 (ORF2 (1-11)) is a bioactive peptide of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (ORF2 (1-11)); Cancer/testis antigen 6.2 (ORF2 (1-11)); L antigen family member 1 (ORF2 (1-11)). | |
| Candelilla wax | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
Our database is helping our users find suppliers everyday.
